The size of the Neurological Monitoring Devices Market in North America was worth USD 3.25 billion in 2022. It is further estimated to be growing at a CAGR of 6.63% and worth USD 4.48 billion by 2027. North America holds the largest market share in the global neurological monitoring devices market.
Due to the advent of wearable medical devices, the greatest shifting trend is observed in the commercialization and commoditization of EEG devices. Manufacturers are introducing disruptive devices that can be used and interpreted easily by a user, which is a growing awareness of neurological disorders at an unprecedented level.
The North American region offers an enormous untapped market for it because of increasing awareness of neurological disorders, a rise in purchasing power, and an increasing number of people with multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s, and Alzheimer’s diseases. Increases in the prevalence of post-surgical cerebrovascular accidents have triggered the need for more improved and automated devices. The high cost of devices is majorly restraining market growth.
This report has been segmented and sub-segmented the North American Neurological Monitoring Devices Market into the following categories:
By Therapeutic Application:
Regionally, the USA is leading the market with the highest number of shares, followed by Canada.
Key market players include CAS Medical Systems Inc., Compumedics Ltd., Natus Medical Inc., Philips Healthcare, GE Healthcare, AMD Global Telemedicine, Intel Corporation, Johnson & Johnson, InTouch Health, InTechnology, MEG International Services Ltd., Rimed Inc., Siemens Healthcare, Medtronic Inc., Electrical Geodesics Incorporated, Nihon Kohden Corporation, and Advanced Brain Monitoring.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com